AG
MGCD

Algert Global’s MGC Diagnostics Corporation MGCD Stock Holding History

Algert Global’s Portfolio MGCD Stock Details MGCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-11,470
Closed -$145K – 400
2013
Q4 		$145K Buy
+11,470
New +$140K 0.04% 332

Other funds holding MGCD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
HAMF
Hatteras Alternative Mutual Funds Raleigh, North Carolina $221M AUM 39.11% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Algert Global's MGCD Position: Q1 2014 in Review

Algert Global sold out of MGC Diagnostics Corporation (MGCD) in Q1 2014, closing a stake of 11,470 shares — an estimated $145K sold.

Algert Global first reported a position in MGCD in Q4 2013 and held it in 1 quarter. The position peaked at $145K in Q4 2013. 22 funds tracked by Wall St. Rank hold MGCD as of Q1 2014.

  • Algert Global reported no remaining MGC Diagnostics Corporation position as of Q1 2014 after selling out during the quarter.
  • Algert Global sold 11,470 MGC Diagnostics Corporation shares in Q1 2014, an estimated $145K.
  • Algert Global first reported a position in MGC Diagnostics Corporation in Q4 2013 and held it in 1 quarter.
  • Algert Global's MGC Diagnostics Corporation position peaked at $145K in Q4 2013.
  • 22 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q1 2014.

Based on Algert Global's 13F filing for Q1 2014, filed 25 Apr 2014.